Export

ATC codes: L01CA04
EMLc
Indication
Rhabdomyosarcoma primary site ICD11 code: 2C25.Z
INN
Vinorelbine
Medicine type
Chemical agent
List type
Complementary (EML)
(EMLc)
Formulations
Parenteral > General injections > IV: 10 mg per mL in 1 mL vial ; 10 mg per mL in 5 mL vial
Oral > Solid: 20 mg ; 30 mg ; 80 mg (EML)
EML status history
First added in 2021 (TRS 1035)
Changed in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended deletion of vinorelbine 80 mg capsules from the EMLc, and modification of the description of the parenteral forms on the EML and EMLc to 10 mg/mL in 1 mL and 5 mL vials.